• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过3型副流感病毒(para 3)的冷适应突变体保护断奶仓鼠免受野生型3型副流感病毒的实验性感染。

Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.

作者信息

Crookshanks-Newman F K, Belshe R B

出版信息

J Med Virol. 1986 Feb;18(2):131-7. doi: 10.1002/jmv.1890180205.

DOI:10.1002/jmv.1890180205
PMID:3005486
Abstract

Parainfluenza virus type 3 (para 3) was adapted to replicate at 20 degrees C, a nonpermissive temperature for wild-type (wt) para 3. Serial passage at 20 degrees C resulted in the generation of cold-adapted (ca) and temperature-sensitive (ts) mutants. These mutant viruses have been characterized both in vitro and in vivo [Belshe and Hissom (1982): Journal of Medical Virology 10:235-242; Crookshanks and Belshe (1984): Journal of Medical Virology 13:243-249]. We now report the evaluation of three mutants (clone 1150, passaged 12 times in the cold [cp12], clone 1146, passaged 18 times in the cold [cp18], and clone 1328, passaged 45 times in the cold [cp45]) for their ability to protect hamsters from infection by wild-type para 3. Ether-anesthetized male syrian hamsters were intranasally vaccinated with either wt para 3 (clone 127) or one of the ca para 3 mutants and on day 28 post-vaccination; each animal was intranasally challenged with 10(5.0) pfu of wt para 3. On days 1, 2, 3, and 4 post-challenge, 4 to 13 hamsters from each group were sacrificed, and the quantity of para 3 in the nasal turbinates and lungs was determined. Wt virus induced protection from challenge. cp12, cp18, and cp45 reduced the peak titer of wt replication in the lungs by greater than 100-fold, tenfold, and tenfold, respectively. The duration of virus replication was shortened also by intranasal vaccination with the mutants. These data give evidence of an inverse relationship between the degree of protection induced by vaccination with cold-adapted mutants and the number of passages of the virus in the cold.

摘要

副流感病毒3型(副3型)经适应后可在20℃复制,这是野生型(wt)副3型的非允许温度。在20℃连续传代导致产生了冷适应(ca)和温度敏感(ts)突变体。这些突变病毒已在体外和体内进行了特性鉴定[贝尔谢和希索姆(1982年):《医学病毒学杂志》10:235 - 242;克鲁克尚克斯和贝尔谢(1984年):《医学病毒学杂志》13:243 - 249]。我们现在报告对三个突变体(克隆1150,在冷环境中传代12次[cp12],克隆1146,在冷环境中传代18次[cp18],以及克隆1328,在冷环境中传代45次[cp45])保护仓鼠免受野生型副3型感染能力的评估。用乙醚麻醉的雄性叙利亚仓鼠经鼻接种wt副3型(克隆127)或其中一个ca副3型突变体,在接种后第28天;每只动物经鼻用10(5.0) 空斑形成单位(pfu)的wt副3型进行攻击。在攻击后第1、2、3和4天,每组4至13只仓鼠被处死,并测定鼻甲和肺中副3型的数量。wt病毒诱导了对攻击的保护作用。cp12、cp18和cp45分别使肺中wt复制的峰值滴度降低了100倍以上、10倍和10倍。用这些突变体经鼻接种也缩短了病毒复制的持续时间。这些数据证明了用冷适应突变体接种诱导的保护程度与病毒在冷环境中的传代次数之间存在反比关系。

相似文献

1
Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.通过3型副流感病毒(para 3)的冷适应突变体保护断奶仓鼠免受野生型3型副流感病毒的实验性感染。
J Med Virol. 1986 Feb;18(2):131-7. doi: 10.1002/jmv.1890180205.
2
Evaluation of cold-adapted and temperature-sensitive mutants of parainfluenza virus type 3 in weanling hamsters.3型副流感病毒冷适应和温度敏感突变体在断奶仓鼠中的评估。
J Med Virol. 1984;13(3):243-9. doi: 10.1002/jmv.1890130306.
3
Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys.冷传代的人副流感3型病毒含有温度敏感(ts)和非温度敏感突变,导致在恒河猴中减毒。
Virus Res. 1992 Mar;22(3):173-84. doi: 10.1016/0168-1702(92)90049-f.
4
A cold-adapted mutant of parainfluenza virus type 3 is attenuated and protective in chimpanzees.副流感病毒3型的冷适应突变株在黑猩猩中减毒且具有保护性。
J Infect Dis. 1993 Apr;167(4):958-62. doi: 10.1093/infdis/167.4.958.
5
Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.在成年志愿者和黑猩猩中对牛源、冷适应人源及野生型人副流感3型病毒的评估。
J Clin Microbiol. 1991 Jun;29(6):1175-82. doi: 10.1128/jcm.29.6.1175-1182.1991.
6
The complete nucleotide sequence of two cold-adapted, temperature-sensitive attenuated mutant vaccine viruses (cp12 and cp45) derived from the JS strain of human parainfluenza virus type 3 (PIV3).两种源自人副流感病毒3型(PIV3)JS株的冷适应、温度敏感减毒突变疫苗病毒(cp12和cp45)的完整核苷酸序列。
Virus Res. 1993 Oct;30(1):43-52. doi: 10.1016/0168-1702(93)90014-e.
7
Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.鉴定导致减毒活冷传代45(cp45)人副流感病毒3候选疫苗温度敏感、冷适应和减毒表型的突变。
J Virol. 1999 Feb;73(2):1374-81. doi: 10.1128/JVI.73.2.1374-1381.1999.
8
Cold adaptation of parainfluenza virus type 3: induction of three phenotypic markers.
J Med Virol. 1982;10(4):235-42. doi: 10.1002/jmv.1890100403.
9
Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.通过导入呼吸道合胞病毒cpts530L聚合酶突变,增强了重组人副流感病毒3型cp45候选疫苗病毒的减毒效果。
Virology. 1999 Jul 20;260(1):125-35. doi: 10.1006/viro.1999.9802.
10
Efficacy of a temperature-sensitive Sendai virus vaccine in hamsters.一种温度敏感型仙台病毒疫苗对仓鼠的疗效。
Lab Anim Sci. 1995 Jun;45(3):233-8.

引用本文的文献

1
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children.两种剂量的减毒重组冷适应人副流感病毒 3 型疫苗 rHPIV3cp45 在 HPIV3 血清阴性的幼儿中的安全性和传染性。
Vaccine. 2013 Nov 19;31(48):5706-12. doi: 10.1016/j.vaccine.2013.09.046. Epub 2013 Oct 5.
2
The cDNA-derived investigational human parainfluenza virus type 3 vaccine rcp45 is well tolerated, infectious, and immunogenic in infants and young children.基于 cDNA 的人副流感病毒 3 型候选疫苗 rcp45 在婴幼儿中具有良好的耐受性、感染性和免疫原性。
Pediatr Infect Dis J. 2011 Oct;30(10):e186-91. doi: 10.1097/INF.0b013e31822ea24f.
3
Parainfluenza viruses.
副流感病毒
Clin Microbiol Rev. 2003 Apr;16(2):242-64. doi: 10.1128/CMR.16.2.242-264.2003.
4
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.利用基于宿主范围减毒的牛副流感病毒3型载体骨架的活cDNA衍生疫苗对恒河猴进行针对呼吸道合胞病毒A和B亚组以及人副流感病毒3型的黏膜免疫。
J Virol. 2002 Feb;76(3):1089-99. doi: 10.1128/jvi.76.3.1089-1099.2002.
5
Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.表达呼吸道合胞病毒(RSV)G蛋白和F蛋白的重组牛/人3型副流感病毒(B/HPIV3)可用于实现针对RSV和HPIV3的同步黏膜免疫。
J Virol. 2001 May;75(10):4594-603. doi: 10.1128/JVI.75.10.4594-4603.2001.
6
Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine.鉴定导致减毒活冷传代45(cp45)人副流感病毒3候选疫苗温度敏感、冷适应和减毒表型的突变。
J Virol. 1999 Feb;73(2):1374-81. doi: 10.1128/JVI.73.2.1374-1381.1999.
7
Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene.人副流感病毒3型候选疫苗株(cp45)的温度敏感表型与L基因缺陷相关。
J Virol. 1996 Jan;70(1):580-4. doi: 10.1128/JVI.70.1.580-584.1996.
8
Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.一种减毒活人类3型副流感病毒候选疫苗株的特性鉴定。
J Virol. 1995 Mar;69(3):1959-63. doi: 10.1128/JVI.69.3.1959-1963.1995.
9
Current approaches to the development of vaccines effective against parainfluenza viruses.开发有效抗副流感病毒疫苗的当前方法。
Bull World Health Organ. 1988;66(3):391-7.
10
Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.人类和非人类灵长类动物在初次感染或再次感染3型副流感病毒后,针对血凝素神经氨酸酶和融合糖蛋白的各个抗原位点的抗体反应。
J Virol. 1990 Aug;64(8):3833-43. doi: 10.1128/JVI.64.8.3833-3843.1990.